.Within this full week's episode of "The Top Line," our team're diving in to Strong Biotech's annual...
.The confetti is still soaring coming from Eli Lilly's gathering commemorating the approval of Alzhe...
.Welcome to this week's Chutes & Ladders, our roundup of notable management hirings, shootings an...
.Observing a bad showing for Lykos Therapies' MDMA candidate for post-traumatic stress disorder at a...
.AN2 Therapeutics is actually re-thinking its business in response to uninspired midphase data, prom...
.Merck & Co. is paying $700 million in advance to test Amgen in a blood stream cancer cells marke...
.Along With Gilead Sciences on the verge of an FDA selection for its own liver illness medicine sela...
.Chief executive officer David Ricks can see the firms putting together camping tents at basecamp be...
.Cushion Liquidators has switched Entero Rehabs white colored as a sheet. The financial institution ...
.Exelixis is giving up on its tissue aspect (TF)- targeting antibody-drug conjugate after ending the...